Asia Knowledge Associates Presents Personal Genomics Conclave & Expo 2014 26 & 27 April 2014, Bangalore, India

Create, collaborate and educate yourself about the future in Genomics.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Genomics has no boundaries and has limitless scope for 7 billion people whose habitat is this planet earth. - Dr. Eric Topol (Author) Creative Destruction of Medicine

Bangalore, India (PRWEB) March 05, 2014

Asia Knowledge Associates is proudly organizing the first of a kind two day event, a conclave and exhibition on personal genomics research and applications named “Personal Genomics Conclave & Expo 2014” to be held on 26th and 27th of April 2014 at the Sheraton Hotel, Bangalore. Whilst the conclave aims to showcase the latest cutting edge research work practiced by eminent scientists across the world, who will be sharing their valuable insights on the potential& promises of genomics and genome analytics and its various applications, the conclave will focus on key developments in the area of human whole genome sequencing, genome testing, genome guided therapy, genome based diagnostics and preventive, personalized medicine, and finally genomics for the study of rare genetic disorders.

The two day conclave will extensively zero in on setting up anunmet curriculum for genomics and training programs in India, through insightful discussions with various stakeholders. The highlight of the conclave will be on Indian Government’s Initiative and policy framework to help strengthen Genomic Research and Clinical Genomics in India, which will be addressed by Dr. V.M. Katoch (Secretary Department of Health Research) & (Director General) Indian Council of Medical Research.

The Human Whole Genome Sequencing (WGS) and Genome Analytics, provides the promise for India to play pioneering role in the global context. It is significantly higher now than ever before notes Dr. Subbu Apparsundaram (Co-founder, CEO& CSO) VClinBio Labs USA &India. "Human genome Sequencing and Genome Analytics entails the study of approximately 30,000 human genes, gene-gene and gene-environment interactions, and the study of multi factorial terminally ill diseases and disease mechanisms. Genomics bound R&D investments will shed immense light into single gene and multi factorial gene diseases, drug safety and efficacy, he concurs. He expects strong dividends and high rewards for investors, industries who stay committed in this Translational Path which has high gestation times,and such research would foster synergy between industry and academia in an industry-institute-interaction.

Mr. M.V. Ramanujam, Director of V Clin Bio Labs USA & India, comments that while it is no more a bottleneck in sequencing of Whole Human Genomes, the Genome Analytics presents a formidable Challenge in terms of data analysis and clinical utility of the interpreted data to Clinicians. With thousands of Human Whole Genomes that are presently getting sequenced around the world, the challenge is that of a human scientific resource, a gap that can be filled by the Indian Scientific and Technology sectors as India is a leader in Information Technology.The readers of this release are bound to be enthralled by the fact that tremendously enhanced current set of applications of NGS Technologies are proving that these platforms are the Core Science to the New Biology, added Mr. M. V.Ramanujam of V ClinBio Labs.

Eminent panelists who would share their valuable insights on various issues at this conclave are:Dr. V.M. Katoch(Indian Council of Medical Research), Prof. Munir(University of Liverpool), Dr. Sandosh Padmanabhan(University of Glasgow), Prof. Aidong Zhang (State University of New York), Dr. Sunita R. Nair (Capita India), Dr. Subbu Apparsundaram (V ClinBio Labs USA& India), Dr. G. R. Sridhar (Endocrine and Diabetes Centre), Dr. Sameek Roychowdhury (The Ohio State University).


Contact